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Abstract 
Background: Jejunal feeding is an invaluable method by which to improve the nutritional status of patients 
undergoing neoadjuvant and surgical treatment of oesophageal malignancies. However, the insertion of a feed‑
ing jejunostomy can cause significant postoperative morbidity. The aim of this study is to compare the outcomes of 
patients undergoing placement of feeding jejunostomy by conventional laparotomy with an alternative laparoscopic 
approach.
Methods: A retrospective review of data prospectively collected at the Oxford Oesophagogastric Centre between 
August 2017 and July 2019 was performed including consecutive patients undergoing feeding jejunostomy insertion.
Results: In the study period, 157 patients underwent jejunostomy insertion in the context of oesophageal cancer 
therapy, 126 (80%) by open technique and 31 (20%) laparoscopic. Pre‑operative demographic and nutritional char‑
acteristics were broadly similar between groups. In the early postoperative period jejunostomy‑associated complica‑
tions were noted in 54 cases (34.4%) and were significantly more common among those undergoing open as com‑
pared with laparoscopic insertion (38.1% vs. 19.3%, P = 0.049). Furthermore, major complications were more common 
among those undergoing open insertion, whether as a stand‑alone or at the time of staging laparoscopy (n = 11/71), 
as compared with insertion at the time of oesophagectomy (n = 3/86, P = 0.011).
Conclusions: This report represents the largest to our knowledge single‑centre comparison of open vs. laparoscopic 
jejunostomy insertion in patients undergoing oesophagectomy in the treatment of gastroesophageal malignancy. We 
conclude that the laparoscopic jejunostomy insertion technique described represents a safe and effective approach 
to enteral access which may offer superior outcomes to conventional open procedures.
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Background
Oesophageal cancer is the eighth most common cancer 
worldwide [1]. It is a highly lethal condition, leading to 
over 400,000 deaths annually [2]. The incidence of weight 
loss in patients with oesophageal cancer is among the 
highest of all cancer types. The majority of patients with 
oesophageal cancer will have experienced a significant 
degree of weight loss by the time of diagnosis and will 
have complex nutritional needs [3]. The effect of such 
weight loss on patient performance status can be detri-
mental to the delivery of gold-standard multimodal treat-
ment strategies and, consequently, can adversely impact 
survival outcomes. The likelihood of encountering severe 
dose-limiting toxicity is substantially greater among indi-
viduals with nutritional deficiency who undergo chemo-
therapy [4]. It is evident, therefore, that the nutritional 
status of patients with oesophageal cancer should be 
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carefully considered during the diagnostic and staging 
phases; and routine nutritional assessment should form 
a central component of the multimodal treatment of 
patients [5].
In their systematic review and meta-analysis of ran-
domized controlled trials, Mazaki and colleagues dem-
onstrated that, when compared to parenteral nutrition, 
enteral nutrition was associated with fewer infectious 
complications, anastomotic leaks, intra-abdominal 
abscesses, overall complications, and decreased length of 
hospital stay [6]. Feeding jejunostomy is the most com-
monly employed approach to enteral nutrition in patients 
undergoing treatment for oesophageal malignancy, given 
that sparing of the stomach is necessary for its potential 
use as a conduit to replace the resected oesophagus.
Jejunostomy insertion can be performed open via lapa-
rotomy, laparoscopically, or by percutaneous techniques 
assisted either endoscopically or using other imaging 
modalities. In patients with severe dysphagia or with 
significant weight loss (≥ 10%) at presentation, a jejunos-
tomy is usually placed at the time of the staging laparos-
copy or as a stand-alone procedure. The goal is to support 
the patient’s nutritional status and hydration during neo-
adjuvant treatment. When a jejunostomy is not indicated 
before neo-adjuvant treatment it is usually placed at the 
time of oesophagectomy to provide fluids and nutrition 
if the oral route is compromised, for instance in the case 
of anastomotic leak. Given the variation in timing and 
technique of jejunostomy insertion, the aim of this study 
is to compare outcomes of subjects undergoing open and 
laparoscopic jejunostomy insertion in the management of 
oesophageal malignancy.
Methods
Retrospective review was performed of databases pro-
spectively compiled between August 2017 and July 2019 
at the Churchill Hospital, Oxford, UK. The indication 
for jejunostomy was decided by multidisciplinary team 
discussion involving surgeons, oncologists, gastroenter-
ologists, and dietitians according to the severity of dys-
phagia, weight loss, and nutritional status. Demographic 
data and baseline patient characteristics including age, 
sex, body mass, preoperative serum albumin, perfor-
mance status (Eastern Cooperative Oncology Group, 
ECOG), American Society of Anaesthesiologists physical 
status classification (ASA grade), TNM staging, relevant 
comoborbidities, and oesophagogastric tumour histology 
were reviewed. All jejunostomy procedure-related com-
plications were collated and classified in accordance with 
Clavien-Dindo (CD) scoring, whereby minor complica-
tions are those scoring 2 or less and major complications 
constitute those scoring 3 or more [7].
Surgical techniques
For both the open and laparoscopic techniques 
described, a 9 Fr feeding jejunostomy tube kit was used 
 (Freka® Surgical Jejunostomy Set  ENFit®, Fresenius 
Kabi). In instances where feeding jejunostomy placement 
was performed at the time of oesophagogastrectomy, lap-
aroscopic insertion was performed where the abdominal 
phase of the resectional procedure was performed mini-
mally invasively. The decision as to whether jejunostomy 
was performed laparoscopically or open at SP was deter-
mined primarily by surgeon preference. Open insertion 
was performed via a midline laparotomy employing the 
Witzel technique—the most common method of jejunos-
tomy creation [8]. The duodenojejunal (DJ) flexure was 
identified and a loop of jejunum selected and confirmed 
to reach the abdominal without excess tension. The jeju-
nostomy tube was introduced into the jejunum using 
the dedicated kit through a purse string suture made 
with absorbable monofilament on the small bowel. A 
2 cm submucosal tunnel was created with the introducer 
and subsequently a short Witzel tunnel made with 3/0 
absorbable monofilament to prevent leak of enteric con-
tent. The small bowel was secured to the abdominal wall 
with parachuting sutures, and the jejunostomy secured 
to the skin with the flange provided using non absorb-
able braided or monofilament sutures. Where open 
jejunostomy was performed concurrently with open 
oesophagectomy, the jejunostomy was introduced via the 
established abdominal incision.
Laparoscopic jejunostomy insertion was performed 
using a three-port technique modified from Senkal and 
colleagues (Fig. 1. An additional movie file demonstrates 
the technique in further detail, see Additional file 1) [9]. 
Briefly, a 12 mm laparoscopic port was placed in the right 
flank to accommodate the laparoscope, and a further two 
5 mm working ports were inserted under vision. The DJ-
flexure was identified, and a loop of proximal jejunum 
confirmed to reach the abdominal wall with ease was 
selected. Placement of two absorbable braided sutures 
in a ‘W’ configuration was performed to define a square 
area that would become the jejunostomy insertion point 
(Fig. 1B). The four ends of the two sutures were retrieved 
outside the abdominal cavity through a 2–3  mm skin 
incision using Endo Close™ Trocar Site Closure Device 
(Covidien, USA), and ensuring that the points of retrieval 
or exit from the peritoneum are adequately spaced to 
mirror the square area created by the sutures placed at 
the jejunum (Fig.  1D). The jejunostomy kit’s introducer 
is inserted through the abdominal wall into the jeju-
num, thereby permitting direct passing of the tube dis-
tally. Positioning is visually verified and tested by saline 
infusion, with vigorous flushing alongside gentle lapa-
roscopic manipulation employed to promote uncoiling 
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where possible. The intra-abdominal pressure is lowered 
to 5 mmHg to enable parachuting of the small bowel up 
to the abdominal wall upon tying of the extracorporeal 
sutures. The procedure is completed by securing the jeju-
nostomy tube using the flange supplied as per the open 
approach aforementioned.
Statistical analyses
Statistical analyses were performed using GraphPad 
Prism v7.0 Software. Group comparisons of continu-
ous variables were performed by t test, where normal-
ity was confirmed using the D’Agostino-Pearson, or by 
Mann–Whitney U test where not normally distributed. 
Chi-square or Fisher’s-exact test, when appropriate, were 
used to compare categorical variables. A P value of less 
than 0.05 was considered significant.
Results
After performing a database search, 175 consecutive 
jejunostomy procedures were identified during the study 
period, 157 of which were associated with the manage-
ment of oesophageal malignancy and therefore eligible 
for inclusion. Of this cohort, 126 subjects underwent 
open jejunostomy insertion while 31 underwent lapa-
roscopic insertion. Comparisons of subject character-
istics between both groups are shown in Table  1, and 
operative approaches to resectional procedures are out-
lined in Table 2. While groups were comparable for sex, 
body mass index (BMI), serum albumin, pre-procedural 
Fig. 1 Laparoscopic Jejunostomy technique. A Two jejunal sutures inserted in ‘W’ configuration leaving an approximately 1  cm2 box target as 
shown in red in schematic representation (B). C Endo Close™ device introduced via a 2–3 mm skin incision for retrieval of suture ends. D peritoneal 
entry must be judged to ensure creation of a 1  cm2 box configuration which mirrors that at the jejunum. E Jejunostomy insertion trocar targeted at 
centre of jejunal box target. F Jejunostomy tube delivered via trocar, with visual confirmation of placement towards distal limb, and saline flush of 
tube for confirmation of patency and positioning. G Antirotation suture placed at nearby distal jejunal limb
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performance status, tumour histology, and tumour stage, 
the laparoscopic group were marginally younger than 
those undergoing open surgery (P = 0.014).
Comparisons of operative outcomes are shown in 
Table  3. Jejunostomy insertion was performed as a 
stand-alone procedure or in conjunction with a laparo-
scopic staging procedure (SP), which is to say prior to 
definitive oesophagectomy, in 71 (45.2%) of 157 cases. 
The remaining 86 (54.8%) cases underwent insertion at 
the time of tumour resection procedure (RP). A trend 
towards a higher incidence of complications was noted 
among those in the ‘staging’ (SP) group (29/71, 40.8%) 
as compared with the RP group (25/86, 29.1%), though 
this did not reach statistical significance (P = 0.12). 
The rate of major complications (CD ≥ 3) however, was 
noted to be significantly higher at SP (P = 0.011), a find-
ing predominantly attributable to the particularly high 
rates of complications seen in cases of open insertion in 
this setting (11/63, 17.5%, P = 0.016).
Table 1 Comparison of preoperative demographic and nutritional variables. n (%)
Open jejunostomy (n = 126) Laparoscopic jejunostomy (n = 31) P value
Age at surgery (years) 66.9 62.6 0.014
Sex is ‘man’ n (%) 99 (79) 21 (68) 0.20
Mean Body Mass Index (kg/m2) 27.9 26.7 0.36
Mean preoperative serum albumin (g/L) 32.3 31.0 0.20
Median performance status (ECOG) 0 0 0.95
TNM
 T 1 7 (6) 4 (13) NS
 2 27 (23) 8 (27)
 3 76 (63) 15 (50)
 4 10 (8) 3 (10)
 N 0 43 (35) 14 (47) NS
 1 54 (44) 13 (43)
 2 22 (18) 3 (10)
 3 4 (3) 0 (‑)
Histology group
 Squamous cell carcinoma 24 (19) 7 (23) NS
 Adenocarcinoma 100 (79) 23 (74)
 Other 2 (2) 1 (3)
ASA Classification
 I 32 (25) 12 (40) NS
 II 89 (71) 18 (60)
 III 6 (4) 0 (‑)
Comorbidities
 None 61 17
 Active Smoker 11 8
 Asthma/COPD 8 5 NS
 Hypertension 30 3
 Coronary artery disease 9 0
 History of stroke 0 1
 Diabetes mellitus 13 3
 Prior abdominal surgery 5 3




 Left‑thoracoabdominal 41 (47)
 Ivor‑Lewis 21 (24)
 Hybrid Ivor‑Lewis (Laparoscopic) 8 (9)
 Minimally invasive 15 (17)
 3‑Stage 1 (1)
Page 5 of 7Mastoridis et al. BMC Surg          (2021) 21:367  
Across all procedures performed, significantly fewer 
complications were encountered following laparoscopic 
insertion as compared with open (P = 0.049). Among the 
subset of cases undergoing jejunostomy insertion at SP, 
a substantially greater proportion of those performed 
open encountered major complications (11, 17.5%), than 
did those performed laparoscopically (0, 0%), though 
not reaching statistical significance (P = 0.34). Similarly, 
in the RP group, 21 major or minor complications were 
encountered among the 63 patients undergoing open 
jejunostomy placement (33.3%), whilst 4 (17.3%) were 
noted among the laparoscopic group (P = 0.19). In this 
setting however, although only jejunostomy-associated 
complications were analysed, the impact of the resec-
tional approach itself is not controlled for. Median length 
of stay was longer amongst those undergoing open pro-
cedures in both the SP (1.5 vs. 3 days, P = 0.17) and the 
RP (9 vs. 10, P = 0.09).
Table 3 Comparison of surgical outcomes among patients with oesophagogastric cancer undergoing laparoscopic or open insertion 
of feeding jejunostomy either at the time of tumour resection procedure (RP) or at a stand‑alone/staging procedure (SP)
n (%). RT return to theatre, IR invasive procedure by interventional radiology
At Staging Procedure (SP) P At Resection Procedure (RP) P
Open (n = 63) Laparoscopic (n = 8) Open (n = 63) Laparoscopic 
(n = 23)
Jejunostomy‑related complications
 Minor complications (CD ≤ 2) 16 (25.4%) 2 (25.0%) 0.99 19 (30.2%) 3 (13.0%) 0.16
  Dislodgement 4 – 1 –
  Leakage – – 2 1
  Infection 5 1 5 0
  Ileus – – 1 –
  Feed related symptoms (diarrhoea, disten‑
sion, pain)
7 1 10 2
(All SP vs. all RP in minor category: P = 0.97)
 Major complications (CD ≥ 3) 11 (17.5%) 0 (0%) 0.34 2 (3.2%) 1 (4.3%) 0.99
  Dislodgement (with RT/IR) 2 – 1 –
  Occlusion (with RT/IR) 2 – 1 –
  Peritonitis/leak 2 – – –
  Wound infection/dehiscence 1 – – –
  Bowel obstruction 4 – – 1
(All SP vs. all RP in major category: P = 0.011)
 Total jejunostomy related complications 27 (42.9%) 2 (25%) 0.46 21 (33.3%) 4 (17.4%) 0.19
(All SP vs. all RP: P = 0.12)
(All Open vs. all Laparoscopic: P = 0.049)
 Clavien‑Dindo Classification of jejunostomy related complications
  Grade I 9 1 0.60 13 2 0.34
  Grade II 7 1 0.27 6 1 0.67
  Grade IIIa 3 – 0.99 – 1 0.27
  Grade IIIb 8 – 0.58 2 – 0.99
  Grade IV – – – – – –
  Grade V 1 – 0.99 – – –
 Resection (non‑jejunostomy) complications
  Anastomotic leak 2 1
  Pneumonia 21 6
  Arrhythmia 7 1
  Chyle leak 4 6
  Return to theatre 1 –
  Thromboembolism 2 –
  Myocardial infarction 1 –
Median length of stay (Days) 3 1.5 0.17 10 9 0.09
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With regards to the small but significant difference 
of approximately 4  years in mean age among groups, 
increasing age was not noted to be associated with higher 
rates of complications (P = 0.10). One death occurred in 
the cohort of 157 cases (0.6%), and this was following 
open jejunostomy insertion at the time of staging. The 
death was associated with the perforation of a closed 
bowel loop involving a segment between the obstructive 
oesophageal tumour and the jejunostomy site.
Discussion
The integration of appropriate nutritional support into 
the overall management of patients undergoing cura-
tive treatment for cancer of the oesophagus is of utmost 
importance to the successful completion of neoadjuvant 
therapy and of surgery, as well as to survival outcomes 
[10, 11]. Feeding jejunostomy is the preferred approach 
to long-term enteral feeding and, since minimally inva-
sive techniques have many advantages, total laparoscopic 
or laparoscopically assisted methods of feeding jejunos-
tomy insertion have garnered increasing attention [12].
This study, which represents the largest to our knowl-
edge comparison of total laparoscopic and open jeju-
nostomy insertion in the setting of oesophageal cancer, 
shows that laparoscopic feeding jejunostomy can be per-
formed safely and has the potential to confer the benefits 
of minimally invasive surgery including lower rates of 
morbidity and shorter hospitalisations. Furthermore, the 
study highlights the risk of major complications among 
subjects undergoing jejunostomy insertion as an open 
stand-alone procedure. This finding is in keeping with the 
literature, wherein reported complication rates for this 
approach range widely but can reach 37% and beyond in 
some series [12, 13]. One explanation for the higher rates 
of complication encountered in stand-alone open inser-
tions is that such procedures are generally performed as 
‘mini-laparotomies’ to avoid the morbidity of larger inci-
sions. As a consequence, they may not afford sufficient 
exposure and access to ensure adequate visualisation of 
the DJ-flexure, jejunum, and abdominal wall. Suboptimal 
exposure can lead to inadvertent injury, kinking or nar-
rowing of the lumen, and difficulties with fixation to the 
abdominal wall. The laparoscopic technique described 
here enabled excellent visualisation of the DJ-flexure and 
of the abdominal wall, and the use of the Endo Close™ 
device makes parachuting the jejunum to the abdomi-
nal wall uncomplicated. The direct puncture of the jeju-
num, without tunnelling, was a source of concern at the 
beginning of our experience, but leakage of enteric con-
tent was encountered in only one case and was success-
fully managed with antibiotics and temporary suspension 
of enteral feeding. A second consideration is that open 
procedures may be performed by less experienced junior 
surgeons as compared with laparoscopic approaches. In 
our series, the number of laparoscopic jejunostomy inser-
tions was relatively lower (31 vs. 126 open) due to the fact 
that only one senior surgeon in our unit employs the lap-
aroscopic technique and, as a consequence, all such pro-
cedures were either performed by this senior surgeon or 
by a junior surgeon under direct supervision. In addition 
to this latter point, this study is limited by the small num-
ber, specifically in the subgroup of procedures performed 
laparoscopically as a staging or stand-alone procedure.
The postoperative mortality in our series of 157 
patients was 0.6%, again mirroring published reports. 
The single death involved a subject with an obstructing 
tumour at the gastro-oesophageal junction, a closed-
loop obstruction which was diagnosed late, and multiple 
comorbidities. While mortality rates are low, the signifi-
cant risks of minor or major complications highlight the 
value of careful patient selection pre-operatively, empha-
sise the importance of patient counselling and informed 
consent, and focus attention on the development of 
improved surgical approaches.
The cost-effectiveness of laparoscopic surgery is often 
questioned. Though not formally assessed in our study, in 
broad terms the cost of the equipment and length of oper-
ation time should be balanced against potential benefits 
regarding the length of stay, cosmesis, reduced analgesic 
requirements, and improved outcomes. It is important to 
note, that laparoscopic jejunostomy insertion was pre-
dominantly performed in conjunction with either staging 
laparoscopy or with minimally invasive oesophagectomy, 
and thereby incurred no significant additional equipment 
costs. This study is limited by its retrospective nature and 
in that data is derived from a single centre. Though this 
represents the largest comparative study of total laparo-
scopic and open jejunostomy insertion in the setting of 
oesophageal cancer, the nevertheless is limited by its rela-
tively small patient population. Future prospective stud-
ies comparing laparoscopic vs. open feeding jejunostomy 
insertion are required to determine the superiority of 
either approach. Our report focuses on patients undergo-
ing treatment for oesophageal malignancy and, however 
likely, it remains to be confirmed whether the findings 
hold true in patients undergoing jejunostomy insertion in 
the contexts of gastric, pancreatic, or hepatic malignan-
cies for instance.
Conclusions
Feeding jejunostomy represents a key adjunct in the 
treatment of oesophageal malignancy. Though consid-
ered by some to be a routine, innocuous procedure, open 
insertion of feeding jejunostomy is a procedure which 
should not be underestimated. Keeping in mind the aims 
of successful neoadjuvant treatment and the reduction of 
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early postoperative morbidity, any complications arising 
from such a procedure could jeopardise potential ben-
efits and incur significant costs. The total laparoscopic 
approach outlined here can serve as a safe, effective alter-
native with the associated advantages of minimally inva-
sive surgery.
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